BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30115992)

  • 21. Dose response of attenuated Bordetella pertussis BPZE1-induced protection in mice.
    Mielcarek N; Debrie AS; Mahieux S; Locht C
    Clin Vaccine Immunol; 2010 Mar; 17(3):317-24. PubMed ID: 20107007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Live attenuated pertussis vaccine BPZE1 induces a broad antibody response in humans.
    Lin A; Apostolovic D; Jahnmatz M; Liang F; Ols S; Tecleab T; Wu C; van Hage M; Solovay K; Rubin K; Locht C; Thorstensson R; Thalen M; Loré K
    J Clin Invest; 2020 May; 130(5):2332-2346. PubMed ID: 31945015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Construction and evaluation of a pertactin-deficient live attenuated pertussis vaccine candidate BPZE1 derivative.
    Solans L; Debrie AS; Coutte L; Locht C
    Vaccine; 2021 May; 39(21):2843-2849. PubMed ID: 33896662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attenuated Bordetella pertussis BPZE1 as a live vehicle for heterologous vaccine antigens delivery through the nasal route.
    Li R; Lim A; Alonso S
    Bioeng Bugs; 2011; 2(6):315-9. PubMed ID: 22067832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A live attenuated Bordetella pertussis candidate vaccine does not cause disseminating infection in gamma interferon receptor knockout mice.
    Skerry CM; Cassidy JP; English K; Feunou-Feunou P; Locht C; Mahon BP
    Clin Vaccine Immunol; 2009 Sep; 16(9):1344-51. PubMed ID: 19625486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic stability of the live attenuated Bordetella pertussis vaccine candidate BPZE1.
    Feunou PF; Ismaili J; Debrie AS; Huot L; Hot D; Raze D; Lemoine Y; Locht C
    Vaccine; 2008 Oct; 26(45):5722-7. PubMed ID: 18762220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study.
    Jahnmatz M; Richert L; Al-Tawil N; Storsaeter J; Colin C; Bauduin C; Thalen M; Solovay K; Rubin K; Mielcarek N; Thorstensson R; Locht C;
    Lancet Infect Dis; 2020 Nov; 20(11):1290-1301. PubMed ID: 32687804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-specific Effects of Live Attenuated Pertussis Vaccine Against Heterologous Infectious and Inflammatory Diseases.
    Cauchi S; Locht C
    Front Immunol; 2018; 9():2872. PubMed ID: 30581436
    [No Abstract]   [Full Text] [Related]  

  • 29. B-cell responses after intranasal vaccination with the novel attenuated Bordetella pertussis vaccine strain BPZE1 in a randomized phase I clinical trial.
    Jahnmatz M; Amu S; Ljungman M; Wehlin L; Chiodi F; Mielcarek N; Locht C; Thorstensson R
    Vaccine; 2014 Jun; 32(27):3350-6. PubMed ID: 24793938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine.
    Ross PJ; Sutton CE; Higgins S; Allen AC; Walsh K; Misiak A; Lavelle EC; McLoughlin RM; Mills KH
    PLoS Pathog; 2013; 9(4):e1003264. PubMed ID: 23592988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis.
    Mills KH; Ryan M; Ryan E; Mahon BP
    Infect Immun; 1998 Feb; 66(2):594-602. PubMed ID: 9453614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attenuated Bordetella pertussis vaccine candidate BPZE1 promotes human dendritic cell CCL21-induced migration and drives a Th1/Th17 response.
    Fedele G; Bianco M; Debrie AS; Locht C; Ausiello CM
    J Immunol; 2011 May; 186(9):5388-96. PubMed ID: 21430219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Live attenuated B. pertussis BPZE1 rescues the immune functions of Respiratory Syncytial virus infected human dendritic cells by promoting Th1/Th17 responses.
    Schiavoni I; Fedele G; Quattrini A; Bianco M; Schnoeller C; Openshaw PJ; Locht C; Ausiello CM
    PLoS One; 2014; 9(6):e100166. PubMed ID: 24967823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-species protection mediated by a Bordetella bronchiseptica strain lacking antigenic homologs present in acellular pertussis vaccines.
    Sukumar N; Sloan GP; Conover MS; Love CF; Mattoo S; Kock ND; Deora R
    Infect Immun; 2010 May; 78(5):2008-16. PubMed ID: 20176797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bystander activation of Bordetella pertussis-induced nasal tissue-resident memory CD4 T cells confers heterologous immunity to Klebsiella pneumoniae.
    Curham LM; Mannion JM; Daly CM; Wilk MM; Borkner L; Lalor SJ; McLoughlin RM; Mills KHG
    Eur J Immunol; 2023 May; 53(5):e2250247. PubMed ID: 36681765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucosal Immunization Against Pertussis: Lessons From the Past and Perspectives.
    Dubois V; Locht C
    Front Immunol; 2021; 12():701285. PubMed ID: 34211481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and immunogenicity of live, attenuated intranasal Bordetella pertussis vaccine (BPZE1) in healthy adults.
    Buddy Creech C; Jimenez-Truque N; Kown N; Sokolow K; Brady EJ; Yoder S; Solovay K; Rubin K; Noviello S; Hensel E; Selamawi S; Bakare A; Makowski M; Lu K
    Vaccine; 2022 Nov; 40(47):6740-6746. PubMed ID: 36220716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intranasal immunization with outer membrane vesicle pertussis vaccine confers broad protection through mucosal IgA and Th17 responses.
    Raeven RHM; Rockx-Brouwer D; Kanojia G; van der Maas L; Bindels THE; Ten Have R; van Riet E; Metz B; Kersten GFA
    Sci Rep; 2020 Apr; 10(1):7396. PubMed ID: 32355188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Pertussis Outer Membrane Vesicle-Based Vaccine Induces Lung-Resident Memory CD4 T Cells and Protection Against
    Zurita ME; Wilk MM; Carriquiriborde F; Bartel E; Moreno G; Misiak A; Mills KHG; Hozbor D
    Front Cell Infect Microbiol; 2019; 9():125. PubMed ID: 31106160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lung pathology and immediate hypersensitivity in a mouse model after vaccination with pertussis vaccines and challenge with Bordetella pertussis.
    Vandebriel RJ; Gremmer ER; Vermeulen JP; Hellwig SM; Dormans JA; Roholl PJ; Mooi FR
    Vaccine; 2007 Mar; 25(12):2346-60. PubMed ID: 17224216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.